A Cost Comparison of Split-Dose Reduced-Volume oral Sulfate Solution (OSS) And Polyethylene Glycol With Electrolytes Solution (Peg-Els)

Presented at the ISPOR 20th Annual International Meeting, Philadelphia, PA, USA, May 16–20, 2015 Funding and other disclosures statement: This research was funded by Braintree Laboratories, Inc. Mark Cleveland is an employee of Braintree Laboratories, Inc. Francis A. Farraye is a research consultant for Braintree Laboratories. Romaine Campbell, Lynn Huynh, and Mihran Yenikomshian are employees of Analysis Group, Inc., which received research grant from Braintree Laboratories, Inc. *During the cost model’s development, Sander Yermakov and Matthew Davis were employees of Analysis Group, Inc. BACKGROUND